Crimean-Congo haemorrhagic fever (CCHF) virus-specific antibody detection in blood donors, Castile-León, Spain, summer 2017 and 2018

[ENG]Background Crimean-Congo haemorrhagic fever virus (CCHFV) is considered an emerging or even a probable re-emerging pathogen in southern Europe. Presence of this virus had been reported previously in Spain in 2010. Aim We aimed to evaluate the potential circulation of CCHFV in western Spain with...

Full description

Bibliographic Details
Authors: Monsalve Arteaga, Lía, Muñoz Bellido, Juan Luis, Vieira Lista, María Carmen, Vicente Santiago, María Belén, Fernández Soto, Pedro, Bas, Isabel, Leralta, Nuria, de Ory Manchón, Fernando, Negredo, Ana Isabel, Sánchez Seco, María Paz, Alonso Sardón, Montserrat, Pérez González, Sonia, Jiménez del Bianco, Ana, Blanco Peris, Lydia, Alamo-Sanz, Rufino, Hewson, Roger, Belhassen García, Moncef, Muro Álvarez, Antonio
Format: article
Status:Published version
Publication Date:2020
Country:España
Institution:Universidad de Salamanca (USAL)
Repository:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/154625
Online Access:http://hdl.handle.net/10366/154625
Access Level:Open access
Keyword:Crimean-Congo haemorrhagic fever
Crimean-Congo haemorrhagic fever virus
antibodies
blood donors
Castile-León
Spain
Ticks
Antibodies
Hemorrhagic Fever Virus, Crimean-Congo
Blood Donors
24 Ciencias de la vida
3207.12 Parasitología
virus de la fiebre hemorrágica de Crimea-Congo
garrapatas
donantes de sangre
anticuerpos
Description
Summary:[ENG]Background Crimean-Congo haemorrhagic fever virus (CCHFV) is considered an emerging or even a probable re-emerging pathogen in southern Europe. Presence of this virus had been reported previously in Spain in 2010. Aim We aimed to evaluate the potential circulation of CCHFV in western Spain with a serosurvey in asymptomatic adults (blood donors). Methods During 2017 and 2018, we conducted a CCHFV serosurvey in randomly selected asymptomatic blood donors from western Spain. Three assays using specific IgG antibodies against CCHFV were performed: the VectoCrimea ELISA test, an in-house ELISA and indirect immunofluorescence (EuroImmun) test with glycoprotein and nucleoprotein. Results A total of 516 blood donors participated in this cross-sectional study. The majority of the study participants were male (68.4%), and the mean age was 46.3 years. Most of the participants came from rural areas (86.8%) and 68.6% had contact with animals and 20.9% had animal husbandry practices. One in five participants (109/516, 21.1%) were engaged in at-risk professional activities such as agriculture and shepherding, slaughtering, hunting, veterinary and healthcare work (mainly nursing staff and laboratory technicians). A total of 15.3% of the participants were bitten by ticks in the days or months before the date of sampling. We detected anti-CCHFV IgG antibodies with two diagnostic assays in three of the 516 individuals and with one diagnostic assay in six of the 516 individuals. Conclusion Seroprevalence of CCHFV was between 0.58% and 1.16% in Castile-León, Spain. This is the first study in western Spain that showed circulation of CCHFV in healthy people